SCHEMBL3671730

SCHEMBL3671730

CCCCCCCCCCCCC(CC)C(=O)OCCCCCC

nearest known ligand 0.61

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
CA2 P00918 6/20 0.58
CA1 P00915 3/20 0.58
NAAA Q02083 1/20 0.52
EPHX1 P07099 1/20 0.48
MAPK1 P28482 1/20 0.48
TSHR P16473 3/20 0.47
ZDHHC7 Q9NXF8 1/20 0.46
MAPT P10636 1/20 0.46
HCAR2 Q8TDS4 1/20 0.44
RAD52 P43351 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
FAAH O00519 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3779971 1.00 CA2 (0.58) CA2CA1NAAAEPHX1MAPK1
SCHEMBL7222901 1.00 CA2 (0.58) CA2CA1NAAAEPHX1MAPK1
SCHEMBL10936953 1.00 CA2 (0.58) CA2CA1NAAAEPHX1MAPK1
SCHEMBL6742265 1.00 CA2 (0.58) CA2CA1NAAAEPHX1MAPK1
SCHEMBL7218993 1.00 CA2 (0.58) CA2CA1NAAAEPHX1MAPK1
SCHEMBL7219194 1.00 CA2 (0.58) CA2CA1NAAAEPHX1MAPK1
SCHEMBL42508 1.00 CA2 (0.58) CA2CA1NAAAEPHX1MAPK1
SCHEMBL7217255 1.00 CA2 (0.58) CA2CA1NAAAEPHX1MAPK1
SCHEMBL7218971 1.00 CA2 (0.58) CA2CA1NAAAEPHX1MAPK1
SCHEMBL3454037 1.00 CA2 (0.58) CA2CA1NAAAEPHX1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3941199-A1 STABILIZED THIOKETONE FORMULATIONS Bayer Aktiengesellschaft (DE) 2022-01-26 EP disclosed
WO-2021254752-A1 USE OF DIINDOLYLMETHANE COMPOUNDS FOR TREATING SIGNS OF SKIN AGING UNILEVER IP HOLDINGS B.V. (NL) 2021-12-23 WO disclosed
WO-2020187871-A1 STABILIZED THIOKETONE FORMULATIONS BAYER AKTIENGESELLSCHAFT (DE) 2020-09-24 WO disclosed
US-20200268628-A1 OIL-IN-WATER EMULSION COMPOSITION COMPRISING ETHER OIL L'OREAL (FR) 2020-08-27 US disclosed
EP-3675803-A1 OIL-IN-WATER EMULSION COMPOSITION COMPRISING ETHER OIL L'OREAL (FR) 2020-07-08 EP disclosed
WO-2019044529-A1 OIL-IN-WATER EMULSION COMPOSITION COMPRISING ETHER OIL L'OREAL (FR) 2019-03-07 WO disclosed
US-20180080834-A1 TEMPERATURE INDICATING MEDIUM HORIUCHI ELECTRONICS. CO., LTD (JP) 2018-03-22 US disclosed
EP-3276315-A1 TEMPERATURE-REGULATING MEDIUM Horiuchi Electronics Co. Ltd. (JP) 2018-01-31 EP disclosed
EP-3113847-A1 ANHYDROUS DYEING COMPOSITION AND PROCESS FOR DYEING HAIR Kao Germany GmbH (DE) 2017-01-11 EP disclosed
EP-3113848-A1 ANHYDROUS DYEING COMPOSITION AND PROCESS FOR DYEING HAIR Kao Germany GmbH (DE) 2017-01-11 EP disclosed
US-20080139391-A1 Plant-Activating Agent KAO CORPORATION (JP) 2008-06-12 US disclosed
US-6824835-B2 CONTAINING DIAMOND ABRASIVE; MODIFIED POLYURETHANE FUJI PHOTO FILM CO., LTD. (JP) 2004-11-30 US disclosed
US-6767610-B2 MULTILAYER; BACKING CONTAINING CARBON BLACK FUJI PHOTO FILM CO., INC. (JP) 2004-07-27 US disclosed
CN-1119982-C Stable cosmetic composition UNILEVER NV (NL) 2003-09-03 CN disclosed
US-20030152808-A1 Flexible magnetic recording medium FUJI PHOTO FILM CO., LTD. 2003-08-14 US disclosed
EP-1326238-A2 Flexible magnetic recording medium FUJI PHOTO FILM CO., LTD. (JP) 2003-07-09 EP disclosed
US-20020119344-A1 Multilayer; backing containing carbon black FUJIFILM HOLDINGS CORPORATION (JP) 2002-08-29 US disclosed
EP-1067518-A2 Magnetic recording medium SONY CORPORATION (JP) 2001-01-10 EP disclosed
CN-1275896-A Stable cosmetic composition UNILEVER NV (NL) 2000-12-06 CN disclosed
US-5318826-A Information recording medium comprising a silver nalide light sensitive layer, and two superposed magnetic layers which differ in coercivity KONICA CORPORATION (JP) 1994-06-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200268628-A1 OIL-IN-WATER EMULSION COMPOSITION COMPRISING ETHER OIL LIPC, PHOSPHO1, NAPEPLD CA2 4397/4885CA1 3947/4885NAAA 638/4885
US-20080139391-A1 Plant-Activating Agent OLA1, POF1B, OSBP CA2 454/4885CA1 1210/4885NAAA 209/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.